GGrantIndex
← Leaderboards

S. Michael Owens

University Of Arkansas Med Scis Ltl Rock

$18,891,940
Attributed
$23,633,948
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY200518
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$29,489,116 · 7

By mechanism

U01$14,176,788 · 2
R01$9,457,160 · 3
P01$5,855,168 · 2

Top collaborators

Others in their field

Top investigators on “Methamphetamine

Research focus

MethamphetamineMonoclonal AntibodyBehavioralBrainInnovationPharmaceutical PreparationsMonoclonal AntibodiesDesignPhencyclidineDrug AbusePre-ClinicalSiteHaptensRattusImmunotherapyPreclinical StudySafetyMedicalBaseAffinityAntibodiesDrug Abuse TherapyPreventDrug Kinetics

Grant awards (38)

Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse$516,073
R01 · FY2018 · DA · contact PI
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse$569,602
R01 · FY2017 · DA · contact PI
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND$4,033,814
U01 · FY2016 · DA
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse$648,371
R01 · FY2016 · DA · contact PI
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND$1,843,400
U01 · FY2015 · DA
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse$679,014
R01 · FY2015 · DA · contact PI
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND$3,606,802
U01 · FY2014 · DA
Active Immunization for Treating Methamphetamine Abuse$965,870
U01 · FY2011 · DA · contact PI
Active Immunization for Treating Methamphetamine Abuse$966,958
U01 · FY2010 · DA · contact PI
Active Immunization for Treating Methamphetamine Abuse$945,482
U01 · FY2009 · DA · contact PI
Immunotherapy for Drug Abuse$385,040
R01 · FY2009 · DA · contact PI
Active Immunization for Treating Methamphetamine Abuse$957,317
U01 · FY2008 · DA · contact PI
Antibody-based Therapy for Methamphetamine Abuse$458,481
R01 · FY2008 · DA · contact PI
Immunotherapy for Drug Abuse$429,148
R01 · FY2008 · DA · contact PI
Active Immunization for Treating Methamphetamine Abuse$857,145
U01 · FY2007 · DA · contact PI
Immunotherapy for Drug Abuse$477,066
R01 · FY2007 · DA · contact PI
Antibody-based Therapy for Methamphetamine Abuse$472,364
R01 · FY2007 · DA · contact PI
Antibody-based Therapy for Methamphetamine Abuse$492,556
R01 · FY2006 · DA · contact PI
Immunotherapy for Drug Abuse$433,975
R01 · FY2006 · DA · contact PI
Preclinical Testing of Antibody Therapy for METH Abuse$1,355,439
P01 · FY2005 · DA
Antibody-based Therapy for Methamphetamine Abuse$518,803
R01 · FY2005 · DA
Immunotherapy for Drug Abuse$418,753
R01 · FY2005 · DA
Preclinical Testing of Antibody Therapy for METH Abuse$1,166,679
P01 · FY2004 · DA
Antibody-based Therapy for Methamphetamine Abuse$466,495
R01 · FY2004 · DA
Preclinical Testing of Antibody Therapy for METH Abuse$163,644
P01 · FY2004 · DA
Antibody-based Therapy for Methamphetamine Abuse$69,074
R01 · FY2004 · DA
Preclinical Testing of Antibody Therapy for METH Abuse$1,161,210
P01 · FY2003 · DA
Preclinical Testing of Antibody Therapy for METH Abuse$1,015,797
P01 · FY2002 · DA
ANTIBODY-BASED THERAPY FOR METHAMPHETAMINE ABUSE$393,542
R01 · FY2002 · DA
IMMUNOTHERAPY FOR DRUG ABUSE$349,480
R01 · FY2002 · DA
IMMUNOTHERAPY FOR DRUG ABUSE$152,370
R01 · FY2002 · DA
CORE--ANTIBODY PRODUCTION FACILITY$0
P01 · FY2002 · DA
Preclinical Testing of Antibody Therapy for METH Abuse$992,399
P01 · FY2001 · DA
IMMUNOTHERAPY FOR DRUG ABUSE$387,652
R01 · FY2001 · DA
ANTIBODY-BASED THERAPY FOR METHAMPHETAMINE ABUSE$385,124
R01 · FY2001 · DA
CORE--ANTIBODY PRODUCTION FACILITY$0
P01 · FY2001 · DA
IMMUNOTHERAPY FOR DRUG ABUSE$378,586
R01 · FY2000 · DA
ANTIBODY-BASED THERAPY FOR METHAMPHETAMINE ABUSE$375,591
R01 · FY2000 · DA